Adenoviral Vector Activation of Innate Immunity


Marketed By :  AV Akademikerverlag   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days


Check Your Delivery Options

Rs. 5,066

Availability: In stock

  • Product Description

Revision with unchanged content. Despite widespread functional prominence and utility, modified adenoviruses have yet to prove efficacious as clinical therapeutics in the United States. Extensively characterized, modified, and employed in a multitude of clinical trials and basic research approaches over the past 20 years, adenoviral vectors have fallen short of their promise of achieving clinical efficacy in gene therapy, vaccination, and immunotherapeutic approaches. While this lack of success could be attributed to many causes, the innate immune response to adenoviral infection remains one of the most prominent obstacles to efficacious adenoviral use today. This study summarizes some recent work, using in vitro and in vivo systems, that identifies the particular innate immune responses adenoviral vectors elicit. Additionally, this work highlights some recent advances that have been made in identifying gene families and factors responsible for these responses. This book is addressed to scientists, re­searchers, and medical professionals using adenoviral vectors for therapeutic means as well as researchers using these vectors as gene transfer vehicles for basic science applications.

Product Specifications
SKU :COC26411
AuthorZachary Conrad Hartman
Number of Pages184
Publishing Year8/17/2012
Edition1 st
Book TypePre-clinical medicine: basic sciences
Country of ManufactureIndia
Product BrandAV Akademikerverlag
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29 00:00:00
0 Review(s)